- What's next for BINSA, the House bill restricting China dealsAfter setting the industry ablaze last month, a bipartisan bill aimed at restricting US biotech companies from striking deals with Chinese counterparts is in limbo. The Biotech Investment Nationa…Endpoints · 10d ago↗ source
- Post-Hoc Live: What’s making biotech IPOs work again?Late last year, I found myself talking a lot about what it would take for biotech’s budding rally to become a full one. We had deals, good pipeline readouts and a rising public stock market ...Endpoints · 10d ago↗ source
- BIO San Diego 2026 Executive InterviewsEvery year, the BIO International Convention brings together more than 20,000 leaders from across the global life sciences ecosystem.Fierce Biotech · 10d ago